We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
-1.39%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$345M
AUM Growth
+$21M
(+6.5%)
Cap. Flow
+$33.8M
Cap. Flow
% of AUM
9.8%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
466
New
14
Increased
365
Reduced
39
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$4.2M |
| 2 |
Procter & Gamble
PG
|
+$3.18M |
| 3 |
Apple
AAPL
|
+$2.96M |
| 4 |
Booking.com
BKNG
|
+$2.81M |
| 5 |
Diageo
DEO
|
+$2.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$3.37M |
| 2 |
NVIDIA
NVDA
|
+$3.35M |
| 3 |
On Holding
ONON
|
+$2.92M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$2.64M |
| 5 |
ASML
ASML
|
+$2.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.24% |
| 2 | Consumer Discretionary | 20.57% |
| 3 | Healthcare | 19.52% |
| 4 | Communication Services | 8.19% |
| 5 | Consumer Staples | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Amphastar Pharmaceuticals
AMPH
$850M
| $58K | 0.02% |
1,261
+628
| +99% | +$34.3K |
|
227
Xenon Pharmaceuticals
XENE
$6.31B
| $56.4K | 0.02% |
1,651
+818
| +98% | +$30.6K |
|
228
Beam Therapeutics
BEAM
$2.76B
| $54.6K | 0.02% |
2,272
+1,037
| +84% | +$27.8K |
|
229
Ambarella
AMBA
$3.66B
| $53K | 0.02% |
1,000
| – | – |
|
|
VTYX
230
DELISTED
Ventyx Biosciences
VTYX
| $52.3K | 0.02% |
1,506
+739
| +96% | +$25.5K |
|
231
JD.com
JD
$42.7B
| $51.1K | 0.01% |
1,754
+1,042
| +146% | +$36.3K |
|
232
Harmony Biosciences
HRMY
$2.32B
| $50.2K | 0.01% |
1,533
+748
| +95% | +$26K |
|
233
Lucid Motors
LCID
$2.58B
| $47.3K | 0.01% |
847
+640
| +309% | +$41.4K |
|
|
ACLX
234
DELISTED
Arcellx
ACLX
| $44.8K | 0.01% |
1,248
+619
| +98% | +$21.3K |
|
235
NovoCure
NVCR
$2.05B
| $44.2K | 0.01% |
2,739
+1,347
| +97% | +$38.8K |
|
236
PTC Therapeutics
PTCT
$6.06B
| $43.5K | 0.01% |
1,941
+969
| +100% | +$36K |
|
237
Immunocore
IMCR
$1.77B
| $43.4K | 0.01% |
836
+426
| +104% | +$25.2K |
|
238
STAAR Surgical
STAA
$1.27B
| $42.9K | 0.01% |
1,067
-43,138
| -98% | -$2.02M |
|
239
Rocket Pharmaceuticals
RCKT
$374M
| $42.4K | 0.01% |
2,068
+1,014
| +96% | +$18.4K |
|
240
Crinetics Pharmaceuticals
CRNX
$8.96B
| $41.7K | 0.01% |
1,403
+695
| +98% | +$14.3K |
|
241
Veracyte
VCYT
$3.59B
| $41.6K | 0.01% |
1,862
+913
| +96% | +$23.5K |
|
242
Recursion Pharmaceuticals
RXRX
$1.76B
| $40.1K | 0.01% |
5,237
+2,817
| +116% | +$28.1K |
|
243
IDEAYA Biosciences
IDYA
$3.56B
| $39.8K | 0.01% |
1,474
+723
| +96% | +$18.3K |
|
|
CVAC
244
DELISTED
CureVac
CVAC
| $39.2K | 0.01% |
5,738
+2,804
| +96% | +$24.8K |
|
245
Supernus Pharmaceuticals
SUPN
$2.78B
| $38.6K | 0.01% |
1,401
+687
| +96% | +$20.9K |
|
246
Ironwood Pharmaceuticals
IRWD
$714M
| $38.5K | 0.01% |
3,997
+1,961
| +96% | +$19.2K |
|
247
Genmab
GMAB
$19.3B
| $37.9K | 0.01% |
1,075
+498
| +86% | +$19K |
|
|
CBAY
248
DELISTED
Cymabay Therapeutics
CBAY
| $37.5K | 0.01% |
2,516
+1,238
| +97% | +$16.4K |
|
|
SWTX
249
DELISTED
SpringWorks Therapeutics
SWTX
| $37.3K | 0.01% |
1,612
+792
| +97% | +$21.7K |
|
250
Pacira BioSciences
PCRX
$945M
| $36.4K | 0.01% |
1,185
+583
| +97% | +$21K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q3 2023 Portfolio in Review
As of Q3 2023, China Universal Asset Management Company held 466 positions worth $345M, up 6.5% from $324M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
China Universal Asset Management Company deployed $33.8M of net new capital in Q3 2023, opening 14 new positions and adding to 365 existing holdings. Its largest new stake was SPDR Gold MiniShares Trust: 71,700 shares worth $2.63M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was TSMC, an estimated $3.37M trimmed.
- China Universal Asset Management Company's largest Q3 2023 buy was SPDR Gold MiniShares Trust: 71,700 shares worth $2.63M.
- China Universal Asset Management Company added most to Amazon in Q3 2023, an estimated $4.2M increase.
- China Universal Asset Management Company's biggest Q3 2023 reduction was TSMC, cutting an estimated $3.37M.
- China Universal Asset Management Company fully exited Carnival Corporation Ltd in Q3 2023, selling an estimated $2.64M.
- China Universal Asset Management Company's ten largest holdings make up 33% of its $345M portfolio in Q3 2023.
- China Universal Asset Management Company opened 14 new positions and closed 20 in Q3 2023.
- China Universal Asset Management Company's portfolio value rose 6.5% quarter-over-quarter to $345M.
Based on China Universal Asset Management Company's 13F filing for Q3 2023, filed 31 Oct 2023.